204
Participants
Start Date
November 1, 2017
Primary Completion Date
October 23, 2018
Study Completion Date
November 12, 2018
5 mg Serlopitant Tablets
Serlopitant Tablets
Matching Placebo Tablets
Placebo Tablets
Study Site 500, New York
Study Site 375, Forest Hills
Study Site 211, Broomall
Study Site 336, Richmond
Study Site 217, Norfolk
Study Site 206, Sanford
Study Site 210, Coral Gables
Study Site 331, Miami
Study Site 222, North Miami Beach
Study Site 348, Miami
Study Site 212, Clearwater
Study Site 205, Murfreesboro
Study Site 228, Louisville
Study Site 216, Louisville
Study Site 516, Bexley
Study Site 207, South Bend
Study Site 360, New Albany
Study Site 219, Clinton Township
Study Site 506, Ann Arbor
Study Site 209, Fridley
Study Site 371, Saint Joseph
Study Site 227, Omaha
Study Site 221, Bryant
Study Site 339, Plano
Study Site 224, Houston
Study Site 223, Sugar Land
Study Site 226, Webster
Study Site 182, College Station
Study Site 203, San Antonio
Study Site 359, Pflugerville
Study Site 213, Boise
Study Site 220, Beverly Hills
Study Site 376, Santa Monica
Study Site 356, San Diego
Study Site 202, San Diego
Study Site 215, San Diego
Study Site 204, Fremont
Study Site 201, East Windsor
Study Site 345, Johnston
Vyne Therapeutics Inc.
INDUSTRY